Indexed on: 29 May '18Published on: 29 May '18Published in: Trends in Molecular Medicine
DNA-based nanorobots have been shown to sense and respond to molecular triggers, such as intracellular pH and cell surface receptors. A recent report describes DNA nanorobots as potential cancer therapeutic agents that can be programmed to trigger coagulation inside blood vessels at the tumor site, starving tumor cells to death. Copyright © 2018 Elsevier Ltd. All rights reserved.